Research Topics
Species | Alan SchatzbergSummaryAffiliation: Stanford University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorderJay D Amsterdam
Depression Research Unit, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 3309, USA
Neuropsychobiology 59:227-33. 2009..The aim of this post hoc analysis was to examine whether tachyphylaxis occurs after repeated courses of antidepressant drug therapy...
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocolLeanne M Williams
BRAINnet Foundation, 71 Stephenson Street, Suite 400, San Francisco, CA, 94105, USA
Trials 12:4. 2011..The aim of iSPOT-D is to identify pretreatment measures that predict or moderate MDD treatment response or remission to escitalopram, sertraline or venlafaxine; and develop a model that incorporates multiple predictors and moderators...
Introduction: treating depression and anxiety to remissionAlan F Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif 94305-55717, USA
J Clin Psychiatry 64:3-4. 2003
Glucocorticoid antagonists in neuropsychiatric [corrected] disordersAlan F Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, United States
Eur J Pharmacol 583:358-64. 2008..g., Alzheimer's disease and mild cognitive impairment), cognitive side effects of electroconvulsive therapy, and weight gain with atypical antipsychotic agents. Potential benefits and limitations are discussed...
The relationship of chronic pain and depressionAlan F Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto 94305-5717, USA
J Clin Psychiatry 65:3-4. 2004
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is notAlan F Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5717, USA
Arch Gen Psychiatry 62:513-20. 2005..Although various strategies are available to manage nonresponders to an initial treatment for depression, no controlled trials address the utility of switching from an antidepressant medication to psychotherapy or vice versa...
Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional researchAlan F Schatzberg
Stanford University School of Medicine, Stanford, Calif 94305 5717, USA
J Clin Psychiatry 67:27-30. 2006..This article summarizes recommendations with respect to future research as well as clinical management recommendations for SRI discontinuation syndrome...
Pharmacologic treatments of major depression: are two mechanisms really better than one?Alan F Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif 94305 5717, USA
J Clin Psychiatry 65:3-4. 2004
Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorderAlan F Schatzberg
Department of Psychiatry, Stanford University School of Medicine, Stanford, CA 94305 5717, USA
J Clin Psychiatry 64:30-7. 2003..The continued presence of such symptoms may predict relapse. Accordingly, it is hoped that duloxetine therapy may reduce the likelihood of depressive relapse...
Clinical use of nefazodone in major depression: a 6-year perspectiveAlan F Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Calif 94305-5717, USA
J Clin Psychiatry 63:18-31. 2002
New approaches to managing psychotic depressionAlan F Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305 5717, USA
J Clin Psychiatry 64:19-23. 2003..This article focuses on recognizing the features of psychotic depression, the success of current treatment options, and new treatments under investigation...
The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patientsGreer M Murphy
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305, USA
Biol Psychiatry 54:665-73. 2003..We hypothesized that epsilon4 carriers would show impaired antidepressant response...
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depressionMichael E Thase
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, PA 15213 2593, USA
J Clin Psychiatry 63:493-500. 2002..As nefazodone-mediated blockade of serotonin-2 receptors may directly relieve insomnia associated with depression, we examined the more specific effects of CBASP and nefazodone, singly and in combination, on sleep disturbances...
HPA axis activation in major depression and response to fluoxetine: a pilot studyElizabeth A Young
Department of Psychiatry, The Mental Health Research Institute, University of Michigan, 205 Zina Pitcher Place, Ann Arbor, MI 48109 0729, USA
Psychoneuroendocrinology 29:1198-204. 2004..This may reflect the greater severity of subjects with HPA axis dysregulation or the need to normalize the HPA axis with medications for optimal response...
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP TrialJames H Kocsis
Department of Psychiatry, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, USA
Arch Gen Psychiatry 66:1178-88. 2009..Previous studies have found that few chronically depressed patients remit with antidepressant medications alone...
Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patientsAlan F Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Rm 300, Stanford, CA 94305-5548, USA
Am J Geriatr Psychiatry 10:541-50. 2002..Mirtazapine also demonstrated a better tolerability profile and represents a valuable option for the treatment of depression in elderly patients...
Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depressionGreer M Murphy
Neuroscience Research Laboratories, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif, USA
Arch Gen Psychiatry 61:1163-9. 2004..Some but not all studies have found that the short form of 5HTTLPR (S allele) results in decreased efficacy of selective serotonin reuptake inhibitors...
A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic featuresAnthony J Rothschild
Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA 01605, USA
J Clin Psychopharmacol 24:365-73. 2004....
Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetineFrederick Reimherr
Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
Psychiatry Res 175:67-73. 2010..Although this study is speculative, it represents a pharmacologically and genotypically well-defined patient population...
A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depressionAlan Schatzberg
Stanford University School of Medicine, Stanford, CA 94605 5548, USA
Am J Geriatr Psychiatry 14:361-70. 2006..This masked, placebo-controlled trial assessed the efficacy and safety of venlafaxine and fluoxetine in depressed patients older than 65 years...
Employing pharmacologic treatment of bipolar disorder to greatest effectAlan F Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305-6811, USA
J Clin Psychiatry 65:15-20. 2004..Lamotrigine stabilizes mood by reducing depression. The atypical anti-psychotics have been shown to be effective either as monotherapy or in combination with mood stabilizers...
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combinationRobert M A Hirschfeld
Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston, Texas 77555 0188, USA
Biol Psychiatry 51:123-33. 2002..This study compared efficacy of nefazodone, psychotherapy, and their combination in improving psychosocial functioning in chronically depressed outpatients...
Monoamine oxidase and catechol-o-methyltransferase enzyme activity and gene expression in response to sustained glucocorticoidsSteven E Lindley
Department of Psychiatry, Veterans Affairs Palo Alto Health Care System, CA 94304, USA
Psychoneuroendocrinology 30:785-90. 2005..The results do not support inhibition of DA metabolism as a mechanism by which glucocorticoids influence DA-mediated behaviors...
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT StudyJames H Kocsis
Department of Psychiatry, Weill Cornell Medical College, New York, NY 10012, USA
J Clin Psychiatry 68:1014-23. 2007..To test the long-term efficacy and safety of venlafaxine extended-release (ER) in preventing recurrence in patients with major depression...
A pilot study of the phase angle between cortisol and melatonin in major depression - a potential biomarker?Theresa M Buckley
Dept of Psychiatry and Behavioral Sciences, Stanford University Medical School, 401 Quarry Road, Stanford, CA 94305 5730, United States
J Psychiatr Res 44:69-74. 2010..In this pilot study, we link cortisol and melatonin rhythms and propose that the phase angle between cortisol acrophase (CA) and dim-light melatonin onset (20 pg/ml) (DLMO-20) may yield a useful state specific biomarker for MDD...
New paradigm for treating recurrent depression: from symptom control to managing enduring vulnerabilitiesAlan F Schatzberg
Stanford University School of Medicine, CA 94605 5548, USA
CNS Spectr 11:22-7. 2006..A new treatment paradigm, which focuses on identifying patients with risk factors and managing the disease process rather than suppression of symptoms, is needed for recurrent depression...
Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot studyNatalie L Rasgon
Stanford Center for Neuroscience in Women s Health, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA
ScientificWorldJournal 10:321-8. 2010..These results suggest the potential novel use for an insulin-sensitizing agent in the treatment of depressive disorders. Larger placebo-controlled studies are warranted...
Extended treatment with bupropion SR for cigarette smoking cessationJoel D Killen
Stanford University School of Medicine, Stanford, CA 94305 5705, USA
J Consult Clin Psychol 74:286-94. 2006..001; week 25: 48% vs. 31%, p = .001; week 52: 39% vs. 27%, p = .01). Because most smokers suffer relapse with any current cessation treatment, the comparatively high abstinence percentages achieved in this trial are of interest...
Using treatment process data to predict maintained smoking abstinenceSteffani R Bailey
Stanford University School of Medicine, Stanford Prevention Research Center, 1070 Arastradero Road, Palo Alto, CA 94304 1334, USA
Am J Health Behav 34:801-10. 2010..To identify distinct subgroups of treatment responders and nonresponders to aid in the development of tailored smoking-cessation interventions for long-term maintenance using signal detection analysis (SDA)...
Aberrant brain activation during a working memory task in psychotic major depressionAmy Garrett
Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, USA
Am J Psychiatry 168:173-82. 2011..The authors sought to better understand the neural circuitry associated with working memory deficits in psychotic major depression by examining brain function during an N-back task...
Effects of major depression diagnosis and cortisol levels on indices of neurocognitive functionRowena G Gomez
Pacific Graduate School of Psychology, 405 Broadway, Redwood City, CA 94063, USA
Psychoneuroendocrinology 34:1012-8. 2009..Our study suggests that cortisol has an independent effect on verbal memory. Also, our study produced evidence of an interaction between diagnosis and cortisol on response inhibition...
The neuropsychological profile of psychotic major depression and its relation to cortisolRowena G Gomez
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5723, USA
Biol Psychiatry 60:472-8. 2006..We predicted that higher cortisol levels would be associated with greater cognitive deficits...
Maternal mediation, stress inoculation, and the development of neuroendocrine stress resistance in primatesKaren J Parker
Department of Psychiatry and Behavioral Sciences, Stanford University, 1201 Welch Road, MSLS P104, Stanford, CA 94305 5485, USA
Proc Natl Acad Sci U S A 103:3000-5. 2006..Results from both experiments demonstrate that stress inoculation, rather than high levels of maternal care, promotes the development of primate stress resistance...
Animal models of early life stress: Implications for understanding resilienceDavid M Lyons
Department of Psychiatry and Behavioral Sciences, Stanford University, 1201 Welch Rd, MSLS P104, Stanford, CA 94305, USA
Dev Psychobiol 52:402-10. 2010..Implications for programs designed to enhance resilience in human development are discussed...
Chronic pain and major depressive disorder in the general populationMaurice M Ohayon
Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, CA 94303, USA
J Psychiatr Res 44:454-61. 2010..It deteriorates physical, occupational and socio-professional activities. Pain and sleep disturbances are a prime motive of consultation rather than depressed mood, underlining the risk of missing a depression diagnosis...
Current issues in the classification of psychotic major depressionJennifer Keller
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5723, USA
Schizophr Bull 33:877-85. 2007..We then propose some improvements to the current unipolar major depression categorization system. Finally, we identify important issues in need of further research to help elucidate the subtype of unipolar PMD...
Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depressionJennifer Keller
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Rd, Stanford, CA 94305 5723, USA
Am J Psychiatry 165:872-80. 2008..The purpose of the present study was to examine differences in hippocampal and amygdalar volumes in patients with depression subtypes relative to healthy comparison subjects...
In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatmentGerald M Reaven
Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
J Psychiatr Res 43:997-1002. 2009..These findings provide a quantitative approach to identify those at greatest treatment-associated risk to develop glucose intolerance, and emphasize the need to address co-morbid medical disorders in these patients...
Withdrawal symptoms over time among adolescents in a smoking cessation intervention: do symptoms vary by level of nicotine dependence?Steffani R Bailey
Stanford University School of Medicine, Stanford Prevention Research Center, Suite 300, Palo Alto, CA 94304 1334, USA
Addict Behav 34:1017-22. 2009..Craving was rated as the most problematic symptom at the baseline assessment. The results of this study may help guide the development of future research on diagnostic and cessation treatment strategies for teens...
Extended cognitive behavior therapy for cigarette smoking cessationJoel D Killen
Stanford University School of Medicine, Stanford, CA 94305 5705, USA
Addiction 103:1381-90. 2008..PRIMARY AIM: Examine the effectiveness of extended cognitive behavior therapy (CBT) in promoting longer-term smoking abstinence...
FKBP5 polymorphisms and antidepressant response in geriatric depressionJane E Sarginson
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5485, USA
Am J Med Genet B Neuropsychiatr Genet 153:554-60. 2010..These results suggest that FKBP5 is unlikely to play a major role in determining antidepressant treatment outcomes in geriatric patients...
Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorderAmit Etkin
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
Arch Gen Psychiatry 66:1361-72. 2009..A functional connectivity approach at the subregional level may therefore yield novel insights into GAD...
The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controlsTheresa M Buckley
Department of Psychiatry and Behavioral Sciences, Stanford University Medical School, CA 94301, USA
Psychoneuroendocrinology 32:859-64. 2007..Herein, we propose that an MR agonist may inhibit the HPA axis without first "unloading" receptors of endogenous cortisol...
Preliminary evidence that hippocampal volumes in monkeys predict stress levels of adrenocorticotropic hormoneDavid M Lyons
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, California 94305 5485, USA
Biol Psychiatry 62:1171-4. 2007..Hippocampal volumes previously determined in monkeys by magnetic resonance imaging are used to test the hypothesis that small hippocampi predict increased stress levels of adrenocorticotropic hormone (ACTH)...
Cortisol circadian rhythm alterations in psychotic major depressionJennifer Keller
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5723, USA
Biol Psychiatry 60:275-81. 2006..There are limited data on cortisol levels during specific times of the day...
From clinical research to clinical practice: a 4-year review of ziprasidoneCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 101 Woodruff Circle, Atlanta, GA 30322, USA
CNS Spectr 10:1-20. 2005..This monograph summarizes the efficacy, tolerability, and safety of oral ziprasidone in the treatment of schizophrenia, schizoaffective disorder, and bipolar mania...
Relating semantic and episodic memory systemsVinod Menon
Department of Psychiatry and Behavioral Sciences, 401 Quarry Road, Stanford University School of Medicine, Stanford, CA 94305 5719, USA
Brain Res Cogn Brain Res 13:261-5. 2002..Here we provide direct evidence for a functional relationship between these two memory systems by showing that left lateral temporal lobe regions involved in semantic memory play an important role in accurate episodic memory retrieval...
Neuroendocrine aspects of hypercortisolism in major depressionKaren J Parker
Department of Psychiatry and Behavioral Sciences, Stanford University Medical School, 1201 Welch Road, MSLS Room P104, Mail Code 5485, Stanford, CA 94305 5485, USA
Horm Behav 43:60-6. 2003..In considering the evidence for hypercortisolism in humans, studies of nonhuman primates are presented and their utility and limitations as comparative models of human depression are discussed...
Cognitive correlates of white matter growth and stress hormones in female squirrel monkey adultsDavid M Lyons
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5485, USA
J Neurosci 24:3655-62. 2004....
Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysisShelley K Fleming
Department of Psychiatry and Behavioral Science, Stanford University School of Medicine, Stanford, CA 94305, USA
J Psychiatr Res 38:27-35. 2004..This review also provides a summary model of the pathophysiology of PMD to provide the necessary context to understanding the biological mechanisms of these impairments...
Pharmacogenetics of antidepressant medication intoleranceGreer M Murphy
Neruroscience Research Laboratories Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford CA 94305 5548, USA
Am J Psychiatry 160:1830-5. 2003..However, variation in genes encoding serotonin receptors could also explain antidepressant side effects (pharmacodynamic effect)...
Early maternal availability and prefrontal correlates of reward-related memoryDavid M Lyons
Department of Psychiatry and Behavioral Science, Stanford University Medical School, Stanford, CA 94305 5485, USA
Neurobiol Learn Mem 80:97-104. 2003..Differences in performance were also discerned after each spatial reversal. These findings indicate that maternal availability alters developing ventral medial prefrontal brain regions involved in reward-related memory...
Regional analysis of hippocampal activation during memory encoding and retrieval: fMRI studyMichael D Greicius
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5719, USA
Hippocampus 13:164-74. 2003..Finally, this study is the first to quantify the effects of susceptibility-induced signal loss on hippocampal activation and suggests that this artifact has significantly biased the interpretation of earlier fMRI studies...
Social phobia and depression: prevalence and comorbidityMaurice M Ohayon
Stanford Sleep Epidemiology Research Center, School of Medicine, Stanford University, Stanford, CA 94303, USA
J Psychosom Res 68:235-43. 2010..Social phobia may seriously impair the functioning of affected individuals. It is frequently associated with other mental disorders...
Mesotelencephalic dopamine neurochemical responses to glucocorticoid administration and adrenalectomy in Fischer 344 and Lewis ratsSteven E Lindley
National Center for PTSD, Department of Veterans Affairs, Palo Alto Health Care Systema, PTSD 352 117, 795 Willow Road, Menlo Park, CA 94025, USA
Brain Res 958:414-22. 2002..The findings indicate a pattern of changes in neurochemical measurements consistent with a small magnitude inhibition of basal dopamine metabolism, but not with a change neuronal activity, release or reuptake...
Prevalence of depressive episodes with psychotic features in the general populationMaurice M Ohayon
Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford Sleep Epidemiology Research Center, 401 Quarry Rd, Suite 3301, Stanford, CA 94305, USA
Am J Psychiatry 159:1855-61. 2002..The study evaluated the prevalence of major depressive episodes with psychotic features in the general population and sought to determine which depressive symptoms are most frequently associated with psychotic features...
Pharmacological principles of antidepressant efficacyAlan F Schatzberg
Department of Psychiatry, Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5717, USA
Hum Psychopharmacol 17:S17-22. 2002..This may help to explain clinical evidence suggesting that mirtazapine has a faster onset of action than the more selective antidepressants...
Experience-dependent asymmetric variation in primate prefrontal morphologyDavid M Lyons
Department of Psychiatry and Behavioral Science, Psychiatry Neuroscience, Stanford University Medical School, 1201 Welch Road, MSLS Room P104, Mail Code 5485, CA 94305 5485, USA
Behav Brain Res 136:51-9. 2002..Follow-up studies now need to determine whether maternal availability directly affects or interacts with subsequent experiences to alter prefrontal substrates of emotional processing and sensitivity to stress...
Prospective investigation of stress inoculation in young monkeysKaren J Parker
Department of Psychiatry and Behavioral Sciences, Stanford University Medical School, Stanford, Calif 94305 5485, USA
Arch Gen Psychiatry 61:933-41. 2004..Retrospective studies in humans have identified characteristics that promote stress resistance, including childhood exposure to moderately stressful events (ie, stress inoculation)...
Mild early life stress enhances prefrontal-dependent response inhibition in monkeysKaren J Parker
Department of Psychiatry and Behavioral Sciences, Stanford University Medical School, Stanford, California 94305 5485, USA
Biol Psychiatry 57:848-55. 2005..e., stress inoculation) strengthens emotional and neuroendocrine resistance to subsequent stressors. Herein we extend this research to examine the effects of mild early life stress on cognition...
On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disordersTheresa M Buckley
Stanford Sleep Disorders Clinic and Research Center and Department of Psychiatry, Stanford University, 401 Quarry Road, Suite 3301, Stanford, California 94305, USA
J Clin Endocrinol Metab 90:3106-14. 2005..Mechanisms by which cortisol can affect slow wave sleep are discussed, as is the role the HPA axis plays in secondary effects of primary sleep disorders...
Clinical and biological effects of mifepristone treatment for psychotic depressionBenjamin H Flores
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305 5723, USA
Neuropsychopharmacology 31:628-36. 2006..These results suggest that short-term use of mifepristone may be effective in the treatment of PMD and may re-regulate the HPA axis. Additional blinded studies are warranted...
Detecting psychotic major depression using psychiatric rating scalesJennifer Keller
Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305 5723, USA
J Psychiatr Res 40:22-9. 2006..The aim of this study was to assess whether individual or clusters of psychiatric symptoms can differentiate patients with psychotic major depression (PMD) from those with nonpsychotic depression (NPMD)...
Mutations in squirrel monkey glucocorticoid receptor impair nuclear translocationSong Her
Department of Psychiatry, Stanford University Medical Center, Stanford, CA 94305 5485, USA
J Steroid Biochem Mol Biol 94:319-26. 2005..Three back-mutations of gsmGR to hGR (Thr551Ser, Ala616Ser, and Ser618Ala) in the LBD confirmed that these amino acids play a role in diminished translocation...
Major depression among adolescent smokers undergoing treatment for nicotine dependenceJoel D Killen
Stanford Prevention Research Center, Stanford University School of Medicine, Hoover Pavilion, Room N072, 211 Quarry Road, CA 94305 5705, USA
Addict Behav 29:1517-26. 2004....
Aging and the role of the HPA axis and rhythm in sleep and memory-consolidationTheresa M Buckley
Stanford Sleep Disorders Clinic and Research Center TMB, Stanford, CA, USA
Am J Geriatr Psychiatry 13:344-52. 2005..In this regard, the authors propose that drugs that act directly on the HPA axis (e.g., mineralocorticoid agonists) may be potentially quite useful for improving both sleep and declarative memory consolidation during sleep...
Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokersJoel D Killen
Department of Medicine, Stanford University, Stanford, CA 94305, USA
J Consult Clin Psychol 72:729-35. 2004..These findings are encouraging and suggest new avenues for research. For example, treatments of the kind examined in this report, augmented by extended maintenance therapies, may yield higher long-term success rates...
Failure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized anxiety disorderAmit Etkin
Department of Psychiatry and Behavioral Sciences, the Center for Interdisciplinary Brain Science Research, and the Program in Neuroscience, Stanford University, USA
Am J Psychiatry 167:545-54. 2010..Here the authors examined whether this form of noninstructed emotion regulation is perturbed in generalized anxiety disorder...
Using chronic pain to predict depressive morbidity in the general populationMaurice M Ohayon
Stanford Sleep Epidemiology Research Center, School of Medicine, Stanford University, 3430 W Bayshore Rd, Suite 102, Palo Alto, CA 94303, USA
Arch Gen Psychiatry 60:39-47. 2003....
Intranasal oxytocin administration attenuates the ACTH stress response in monkeysKaren J Parker
Department of Psychiatry and Behavioral Sciences, Stanford University Medical School, CA 94305 5485, USA
Psychoneuroendocrinology 30:924-9. 2005..This primate model offers critical opportunities to improve our understanding of the anti-stress effects of OT and may lead to novel pharmacological treatments for stress-related psychiatric disorders...
Preliminary evidence that plasma oxytocin levels are elevated in major depressionKaren J Parker
Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, CA 94305, USA
Psychiatry Res 178:359-62. 2010..Additional research is required to elucidate the role of OT in the pathophysiology of this psychiatric disorder...
Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapyJoel D Killen
Departments of Medicine and Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA 94303 1334, USA
Addiction 105:1660-8. 2010..To examine the effectiveness of transdermal selegiline for producing cigarette smoking abstinence...
Animal models of early life stress: implications for understanding resilienceDavid M Lyons
Department of Psychiatry and Behavioral Sciences, Stanford University, CA 94305, USA
Dev Psychobiol 52:616-24. 2010..Implications for programs designed to enhance resilience in human development are discussed...
Early life stress and novelty seeking behavior in adolescent monkeysKaren J Parker
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 1201 Welch Road, MSLS Room P104, Mail Code 5485, Stanford, CA 94305 5485, USA
Psychoneuroendocrinology 32:785-92. 2007..These trait-like differences in novelty seeking appear to reflect mild early stress-induced adaptations that enhance curiosity and resilience...
A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressantsCharles DeBattista
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine Stanford, CA 94305 5723, USA
J Clin Psychopharmacol 23:27-30. 2003..This prospective, open-label trial supports the use of bupropion SR in the augmentation of SSRIs and venlafaxine. Placebo controlled trials should be completed to further evaluate the efficacy of this strategy...
Stress coping stimulates hippocampal neurogenesis in adult monkeysDavid M Lyons
Departments of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA 94305, USA
Proc Natl Acad Sci U S A 107:14823-7. 2010..These findings support recent indications that stress coping stimulates hippocampal neurogenesis in adult rodents. Psychotherapies designed to promote stress coping potentially have similar effects in humans with major depression...
Social stress-related behavior affects hippocampal cell proliferation in miceRupshi Mitra
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5020, USA
Physiol Behav 89:123-7. 2006....
Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamusMichael D Greicius
Department of Neurology and Neurological Sciences, Stanford University Medical Center, Stanford, California 94305 5235, USA
Biol Psychiatry 62:429-37. 2007..The goal of this study was to examine resting-state, default-mode network functional connectivity in subjects with major depression and in healthy controls...
The acute and post-discontinuation effects of a glucocorticoid receptor (GR) antagonist probe on sleep and the HPA axis in chronic insomnia: a pilot studyTheresa Buckley
Department of Psychiatry, Stanford University Medical School, Stanford, CA, USA
J Clin Sleep Med 4:235-41. 2008..Aglucocorticoid receptor (GR) antagonist may re-regulate HPA axis activity even after discontinuation and may have clinical benefit...
Monitoring mental health treatment acceptance and initial treatment adherence in veterans: veterans of Operations Enduring Freedom and Iraqi Freedom versus other veterans of other erasSteven Lindley
Department of Psychiatry, Stanford University School of Medicine, Stanford, California, USA
Ann N Y Acad Sci 1208:104-13. 2010..No variables predicted OEF/OIF acceptance/attendance. In conclusion, our findings illustrate the importance of close, continual monitoring of clinical process data to help reveal targets for improving mental health care for veterans...
Onset of major depression during treatment for nicotine dependenceJoel D Killen
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 1000 Welch Road, Palo Alto, CA 94304, USA
Addict Behav 28:461-70. 2003..The evidence indicates that those who treat nicotine dependence must be prepared to monitor and respond to the emergence of depression associated with treatment...
Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trialJohn Zajecka
Treatment Research Center, Department of Psychiatry, Rush University Medical Center, Chicago, IL 60612, USA
J Clin Psychopharmacol 30:135-44. 2010..The results showed significant antidepressant efficacy of agomelatine 50 mg/d, including a positive effect on sleep compared with placebo in outpatients with moderate to severe major depressive disorder...
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood traumaCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322
Proc Natl Acad Sci U S A 100:14293-6. 2003..Our results suggest that psychotherapy may be an essential element in the treatment of patients with chronic forms of major depression and a history of childhood trauma...
Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placeboRajiv Mallick
Global Health Outcomes Assessment, Wyeth Research, Collegeville, PA, USA
J Clin Psychiatry 64:321-30. 2003..Active treatments were associated with more DFDs than placebo, and venlafaxine with more DFDs than SSRIs, consistent with corresponding differences in sustained remission...
Dissociable intrinsic connectivity networks for salience processing and executive controlWilliam W Seeley
Department of Neurology, School of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
J Neurosci 27:2349-56. 2007..Our findings suggest that task-free analysis of intrinsic connectivity networks may help elucidate the neural architectures that support fundamental aspects of human behavior...
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled studyDavid Michelson
Lilly Research Laboratories, Eli Lilly and Co, Indianapolis, Ind, USA
J Clin Psychiatry 68:582-7. 2007..Addition of a noradrenergic intervention in patients poorly or partially responsive to SSRIs may improve outcomes, but few well-controlled studies testing this hypothesis have been reported...
Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorderStephen K Brannan
Cyberonics, Houston, TX 77058, USA
J Psychiatr Res 39:43-53. 2005..Improvements in pain severity occurred independently of changes in depressive symptom severity...
Depression in the elderlyWilliam M McDonald
Fuqua Center for Late-Life Depression, Emory University, Atlanta, USA
Psychopharmacol Bull 36:112-22. 2002..Treatment should also take into account the likelihood of achieving and maintaining remission of symptoms in order to restore the patient to a baseline level of functioning appropriate for their age...
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phasesMartin B Keller
Brown University, Providence, Rhode Island 02906, USA
Biol Psychiatry 62:1371-9. 2007..We evaluated the comparative efficacy and safety of venlafaxine extended release (ER) and fluoxetine in the acute and continuation phases of treatment...
Slowing the progression of cognitive decline in Alzheimer's disease using mifepristoneJoseph K Belanoff
Corcept Therapeutics, Inc, Menlo Park, CA 94025, USA
J Mol Neurosci 19:201-6. 2002..Additionally, this study test the hypothesis that AD subjects with elevated cortisol at baseline will perform more poorly on neuropsychological exams that do subjects with low cortisol...
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phasesMartin B Keller
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
J Clin Psychiatry 68:1246-56. 2007..To report second-year results from the 2-year maintenance phase of a long-term study to evaluate the efficacy and safety of venlafaxine extended release (ER) in preventing recurrence of depression...
Research Grants
- MODEL OF HYPERCORTISOLISM FOR MAJOR DEPRESSIONSAlan Schatzberg; Fiscal Year: 2004..However, despite some apparent similarities between rodent and primate brain circuits, there is a paucity of data regarding CNS modulation of stress response in primates. ..
- MODEL OF HYPERCORTISOLISM FOR MAJOR DEPRESSIONAlan Schatzberg; Fiscal Year: 2007....
- HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSIONAlan Schatzberg; Fiscal Year: 2007..Of particular importance is that the treatment may be effective even when given intermittently. ..
- REVAMP-Follow-Up StudyAlan Schatzberg; Fiscal Year: 2007....
- A BIOBEHAVIORAL RESEARCH TRAINING PROGRAMAlan Schatzberg; Fiscal Year: 2007....
- HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSIONAlan Schatzberg; Fiscal Year: 2009..Of particular importance is that the treatment may be effective even when given intermittently. ..
- HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSIONAlan Schatzberg; Fiscal Year: 2003..abstract_text> ..
- MODEL OF HYPERCORTISOLISM FOR MAJOR DEPRESSIONSAlan Schatzberg; Fiscal Year: 1999....
- MODEL OF HYPERCORTISOLISM FOR MAJOR DEPRESSIONAlan F Schatzberg; Fiscal Year: 2010....
